Inventor
SIGNAEVSKY MAXIM
CA22 patents
⚠️ This page may combine multiple inventors who share the name “SIGNAEVSKY MAXIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BRITISH COLUMBIA
11 patentsUS7101991B2Sep 5, 2006
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA11 citations91
US7928082B2Apr 19, 2011
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
UNIV BRITISH COLUMBIA3 citations73
US7723312B2May 25, 2010
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA3 citations72
US7550580B2Jun 23, 2009
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA2 citations62
US9580712B2Feb 28, 2017
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA1 citations61
US7820635B2Oct 26, 2010
RNAi probes targeting cancer-related proteins
UNIV BRITISH COLUMBIA2 citations60
US9404109B2Aug 2, 2016
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA0 citations51
US9085769B2Jul 21, 2015
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA0 citations51
US8580761B2Nov 12, 2013
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
UNIV BRITISH COLUMBIA0 citations51
US7847091B2Dec 7, 2010
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA0 citations51
US7964717B2Jun 21, 2011
RNAi probes targeting cancer-related proteins
UNIV BRITISH COLUMBIA0 citations50
GLEAVE MARTIN
5 patentsUS9101646B2Aug 11, 2015
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
GLEAVE MARTIN1 citations62
US8389491B2Mar 5, 2013
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
GLEAVE MARTIN2 citations62
US8772470B1Jul 8, 2014
Compositions and methods for treatment of prostate and other cancers
GLEAVE MARTIN1 citations61
US9487777B2Nov 8, 2016
RNAi probes targeting cancer-related proteins
GLEAVE MARTIN0 citations49
US8759308B2Jun 24, 2014
RNAi probes targeting cancer-related proteins
GLEAVE MARTIN0 citations49
NEUROSILICA INC
4 patentsUS10602939B2Mar 31, 2020
Bi-directional neuron-electronic device interface structures
NEUROSILICA INC4 citations67
US11607161B2Mar 21, 2023
Bi-directional neuron-electronic device interface structures
NEUROSILICA INC0 citations56
US11538947B2Dec 27, 2022
Multilayered composite material utilizing quantum dot based photovoltaic effect for bi-directional brain-computer interface
NEUROSILICA INC0 citations46
US10845667B2Nov 24, 2020
Photosensitive multilayered composite material suitable for eye implants
NEUROSILICA INC0 citations46